Convatec Group PLC - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
CNVVY Over the counter 3850 www.convatecgroup.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Convatec Group PLC

ConvaTec Group H1 Earnings Call Highlights - Aug 4th, 2026 4:03 am
$3.8 Billion Negative Pressure Wound Therapy (NPWT) Devices Market Assessment, 2030 - Featuring Solventum, Smith+Nephew, Cardinal Health, Molnlycke Health Care, ConvaTec Group and Other Key Players - Feb 19th, 2026 4:48 am
UK's February 2026 Stocks Possibly Priced Below Estimated Value - Feb 9th, 2026 11:38 pm
Why The Narrative Around Convatec Group LSE CTEC Is Shifting After Fresh Analyst And Holder Moves - Feb 9th, 2026 8:10 am
UK Value Stocks: Fevertree Drinks Among 3 Selections Possibly Trading Below Fair Value - Jan 11th, 2026 11:38 pm
ConvaTec Group Product Pipeline Analysis Report 2025 | Emphasizing Innovation in Therapies for Chronic Conditions and Exploiting Market-entry, R&D, and In/Out-licensing Strategies - Jan 5th, 2026 8:14 am
With 75% ownership of the shares, Convatec Group PLC (LON:CTEC) is heavily dominated by institutional owners - Dec 14th, 2025 11:18 pm
TIFIN Appoints Andrew Dahlinghaus as Chief Operating Officer - Dec 8th, 2025 7:15 am